Geode Capital Management, LLC 89bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,740,867 shares of ETNB stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,740,867
Previous 1,377,710
26.36%
Holding current value
$16.1 Million
Previous $15.4 Million
31.67%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ETNB
# of Institutions
166Shares Held
89.3MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$116 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$68.2 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$61.3 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$58.2 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$51.2 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $430M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...